Hospitalizations for cardiovascular diseases attributable to tobacco smoking in France in 2015.

AIMS: Tobacco smoking is a major risk factor for many cardiovascular diseases. In France, the daily smoking prevalence is among the highest in high-income European countries. This study estimated the number of hospitalizations for cardiovascular diseases attributable to smoking in France in 2015, and the number of stays that could have been avoided if there had been 10% less current smokers or if the prevalence of current smokers had been 20%. METHODS: Age- and sex-specific attributable fractions were calculated by combining relative risks extracted from the literature with the prevalence of smoking estimated in the 2014 Health Barometer, a national representative survey. These fractions were applied to hospitalization stays with a primary diagnosis for a cardiovascular disease whose risk is known to increase with smoking. RESULTS: In France in 2015, 250,813 hospital stays (95% uncertainty interval=234,869-269,807) related to a cardiovascular condition were estimated as attributable to smoking. This represented 21% of all stays for a cardiovascular condition. Ischemic heart disease accounted for the largest share of smoking-related stays (39%). If the number of current smokers had been 10% lower or if the prevalence of smoking in the population had dropped to below 20%, 5867 stays and 25,911 stays, respectively, would have been prevented. CONCLUSIONS: In France, a large number of hospital stays for cardiovascular disease are attributable to tobacco smoking. A 10% reduction in smoking would avoid nearly 6000 hospital stays per year; more than 25,000 annual hospital stays if only 20% of the French population smoked.

Results of the treatment of benign prostatic hyperplasia by ILC Indigo 830e system

Background: Interstitial Laser Coagulation (ILC) Indigo 830e system is the first technique that is used in Viet Nam for the treatment of Benign Prostatic Hyperplasia (BPH) patients. Objectives: (1) To evaluate the effects of treatment of benign prostatic hyperplasia by ILC Indigo 830e system. (2) To describe peri- and post-proceduce complications. Subjects and method: The study consisted of 106 BPH patients who treated by ILC Indigo 830e system. This was a cross-section, descriptive study. Results: Overally, good and moderate outcomes was 94.8%, unsatisfactory was 5.2%. The peri- and post-proceduce complications were: urethral irritability 20.8%, prolonged catheterization 4.7%, urinary tract infections 4.7% and hematuria 0.94%. Conclusion: The treatment for benign prostatic hyperplasia patients by ILC Indigo 830e system was an effective and safe therapy, especially in elderly patient group who had multiple diseases.

Diagnosis of anatomic variants of the biliary tree by MRCP

Background: Magnetic resonance pancreatography (MRCP) is a safe noninvasive imaging technique that has proven to be accurate in the diagnosis of biliary tract diseases. Objective: To evaluate the role of MRCP in diagnosis of the anatomic variants of the biliary tree. Subjects and method: A retrospective study (from Augusts 2003 to April 2006, at Gia Dinh People Hospital) was conducted in 147 MRCP. All of anatomic variants of the biliary tract were classified. Results: MRCP had the sensitivity of 85.1%, the specificity of 92.1%, and the accuracy of 89.2%. Anatomic variants of the biliary tract included: type I (65%), type II (33.6%), type III (0%), type IV (1.4%). The anatomic variants of extrahepatic biliary tract that had high risk of damaged bile duct during laparoscopic cholecystectomy such as ectopic of right posterior hepatic duct (18.2%) and abnormal of junction of cystic duct and hepatic commune bile duct (2.9 - 44.6%). Conclusions: In this study, MRCP showed the modality of choices in the evaluation of hepatobiliary diseases and the anatomic variants of the biliary tree. MRCP helped the surgeons to avoid the injury of bile ducts during the operations.